15.10.2015 Views

Global Joint Pain Clinical Trials Review Market Trend & Research Report 2015 Radiant Insights, Inc

Summary GlobalData's clinical trial report,Joint Pain Global Clinical Trials Review, H1, 2015" provides an overview of Joint Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Joint Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. View Full Report with TOC @ http://www.radiantinsights.com/research/joint-pain-global-clinical-trials-review-h1-2015 The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage. Scope - The report provides a snapshot of the global clinical trials landscape - Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status - The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company - The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment - The Report provides enrollment trends for the past five years - Report provides latest news for the past three months Reasons to buy - Assists in formulating key business strategies with regards to investment - Helps in identifying prominent locations for conducting clinical trials which saves time and cost - Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities - Supports understanding of trials count and enrollment trends by country in global therapeutics market - Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials - Facilitates clinical trial assessment of the indication on a global, regional and country level

Summary

GlobalData's clinical trial report,Joint Pain Global Clinical Trials Review, H1, 2015" provides an overview of Joint Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Joint Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

View Full Report with TOC @ http://www.radiantinsights.com/research/joint-pain-global-clinical-trials-review-h1-2015

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Global</strong> <strong>Joint</strong> <strong>Pain</strong> <strong>Clinical</strong> <strong>Trials</strong> <strong>Review</strong> <strong>Market</strong> <strong>Trend</strong> & <strong>Research</strong><br />

<strong>Report</strong> <strong>2015</strong>: <strong>Radiant</strong> <strong>Insights</strong>, <strong>Inc</strong><br />

Summary<br />

<strong>Global</strong>Data's clinical trial report,<strong>Joint</strong> <strong>Pain</strong> <strong>Global</strong> <strong>Clinical</strong> <strong>Trials</strong> <strong>Review</strong>, H1, <strong>2015</strong>" provides an<br />

overview of <strong>Joint</strong> <strong>Pain</strong> clinical trials scenario. This report provides top line data relating to the clinical<br />

trials on <strong>Joint</strong> <strong>Pain</strong>. <strong>Report</strong> includes an overview of trial numbers and their average enrollment in top<br />

countries conducted across the globe. The report offers coverage of disease clinical trials by region,<br />

country (G7 & E7), phase, trial status, end points status and sponsor type. <strong>Report</strong> also provides prominent<br />

drugs for in-progress trials (based on number of ongoing trials). <strong>Global</strong> Data <strong>Clinical</strong> Trial <strong>Report</strong>s are<br />

generated using <strong>Global</strong> Data's proprietary database - Pharma eTrack <strong>Clinical</strong> trials database. <strong>Clinical</strong><br />

trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the<br />

globe. <strong>Clinical</strong> trials database undergoes periodic update by dynamic process.<br />

View Full <strong>Report</strong> with TOC @ http://www.radiantinsights.com/research/joint-pain-global-clinicaltrials-review-h1-<strong>2015</strong><br />

The report enhances the decision making capabilities and helps to create an effective counter strategies to<br />

gain competitive advantage.<br />

Scope<br />

- The report provides a snapshot of the global clinical trials landscape<br />

- <strong>Report</strong> provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status,<br />

Trial Phase, Sponsor Type and End point status<br />

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining<br />

to the company<br />

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason<br />

for unaccomplishment<br />

- The <strong>Report</strong> provides enrollment trends for the past five years<br />

- <strong>Report</strong> provides latest news for the past three months<br />

Reasons to buy<br />

- Assists in formulating key business strategies with regards to investment<br />

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost


- Provides top level analysis of <strong>Global</strong> <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong> which helps in identifying key business<br />

opportunities<br />

- Supports understanding of trials count and enrollment trends by country in global therapeutics market<br />

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed<br />

and uncompleted (terminated, suspended or withdrawn) trials<br />

- Facilitates clinical trial assessment of the indication on a global, regional and country level<br />

Table of Contents<br />

Table of Contents 2<br />

List of Tables 4<br />

List of Figures 5<br />

Introduction 6<br />

<strong>Joint</strong> <strong>Pain</strong> 6<br />

View Full <strong>Report</strong> with TOC @ http://www.radiantinsights.com/research/joint-pain-global-clinicaltrials-review-h1-<strong>2015</strong><br />

<strong>Report</strong> Guidance 6<br />

<strong>Clinical</strong> <strong>Trials</strong> by Region 7<br />

<strong>Clinical</strong> <strong>Trials</strong> and Average Enrollment by Country 8<br />

Top Five Countries Contributing to <strong>Clinical</strong> <strong>Trials</strong> in Asia-Pacific 10<br />

Top Five Countries Contributing to <strong>Clinical</strong> <strong>Trials</strong> in Europe 11<br />

Top Countries Contributing to <strong>Clinical</strong> <strong>Trials</strong> in North America 12<br />

Top Countries Contributing to <strong>Clinical</strong> <strong>Trials</strong> in Middle East and Africa 13<br />

Top Countries Contributing to <strong>Clinical</strong> <strong>Trials</strong> in Central and South America 14<br />

<strong>Clinical</strong> <strong>Trials</strong> by G7 Countries: Proportion of <strong>Joint</strong> <strong>Pain</strong> to Central Nervous System <strong>Clinical</strong> <strong>Trials</strong> 15<br />

<strong>Clinical</strong> <strong>Trials</strong> by Phase in G7 Countries 16<br />

<strong>Clinical</strong> <strong>Trials</strong> in G7 Countries by Trial Status 17<br />

<strong>Clinical</strong> <strong>Trials</strong> by E7 Countries: Proportion of <strong>Joint</strong> <strong>Pain</strong> to Central Nervous System <strong>Clinical</strong> <strong>Trials</strong> 18


<strong>Clinical</strong> <strong>Trials</strong> by Phase in E7 Countries 19<br />

<strong>Clinical</strong> <strong>Trials</strong> in E7 Countries by Trial Status 20<br />

<strong>Clinical</strong> <strong>Trials</strong> by Phase 21<br />

In Progress <strong>Trials</strong> by Phase 22<br />

<strong>Clinical</strong> <strong>Trials</strong> by Trial Status 23<br />

<strong>Clinical</strong> <strong>Trials</strong> by End Point Status 24<br />

Unaccomplished <strong>Trials</strong> of <strong>Joint</strong> <strong>Pain</strong> 25<br />

Subjects Recruited Over a Period of Time 28<br />

<strong>Clinical</strong> <strong>Trials</strong> by Sponsor Type 29<br />

Prominent Sponsors 30<br />

Top Companies Participating in <strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> 31<br />

View Full <strong>Report</strong> with TOC @ http://www.radiantinsights.com/research/joint-pain-global-clinicaltrials-review-h1-<strong>2015</strong><br />

Prominent Drugs 32<br />

<strong>Clinical</strong> Trial Profiles 33<br />

<strong>Clinical</strong> Trial Overview of Top Companies 33<br />

Novartis AG 33<br />

<strong>Clinical</strong> Trial Overview of Novartis AG 33<br />

Johnson & Johnson 34<br />

<strong>Clinical</strong> Trial Overview of Johnson & Johnson 34<br />

Endo International Plc 35<br />

<strong>Clinical</strong> Trial Overview of Endo International Plc 35<br />

Arthritis <strong>Research</strong> UK 36<br />

<strong>Clinical</strong> Trial Overview of Arthritis <strong>Research</strong> UK 36<br />

APIGENEX s.r.o. 37<br />

<strong>Clinical</strong> Trial Overview of APIGENEX s.r.o. 37


Amgen <strong>Inc</strong>. 38<br />

<strong>Clinical</strong> Trial Overview of Amgen <strong>Inc</strong>. 38<br />

AlgoRx Pharmaceuticals, <strong>Inc</strong>. (Inactive) 39<br />

<strong>Clinical</strong> Trial Overview of AlgoRx Pharmaceuticals, <strong>Inc</strong>. (Inactive) 39<br />

Actavis Plc 40<br />

<strong>Clinical</strong> Trial Overview of Actavis Plc 40<br />

Accutest <strong>Research</strong> Laboratories (I) Pvt. Ltd. 41<br />

<strong>Clinical</strong> Trial Overview of Accutest <strong>Research</strong> Laboratories (I) Pvt. Ltd. 41<br />

ABsize <strong>Inc</strong>. 42<br />

<strong>Clinical</strong> Trial Overview of ABsize <strong>Inc</strong>. 42<br />

<strong>Clinical</strong> Trial Overview of Top Institutes / Government 43<br />

View Full <strong>Report</strong> with TOC @ http://www.radiantinsights.com/research/joint-pain-global-clinicaltrials-review-h1-<strong>2015</strong><br />

Baylor Breast Care Center 43<br />

<strong>Clinical</strong> Trial Overview of Baylor Breast Care Center 43<br />

Creighton University 44<br />

<strong>Clinical</strong> Trial Overview of Creighton University 44<br />

Iran University of Medical Sciences 45<br />

<strong>Clinical</strong> Trial Overview of Iran University of Medical Sciences 45<br />

National Center for Complementary and Integrative Health 46<br />

<strong>Clinical</strong> Trial Overview of National Center for Complementary and Integrative Health 46<br />

National Institute of Siddha 47<br />

<strong>Clinical</strong> Trial Overview of National Institute of Siddha 47<br />

Shiraz University of Medical Sciences 48<br />

<strong>Clinical</strong> Trial Overview of Shiraz University of Medical Sciences 48<br />

The Johns Hopkins University 49


<strong>Clinical</strong> Trial Overview of The Johns Hopkins University 49<br />

Appalachian State University 50<br />

<strong>Clinical</strong> Trial Overview of Appalachian State University 50<br />

Bharati Vidyapeeth Deemed University 51<br />

<strong>Clinical</strong> Trial Overview of Bharati Vidyapeeth Deemed University 51<br />

Central Council for <strong>Research</strong> in Unani Medicine 52<br />

<strong>Clinical</strong> Trial Overview of Central Council for <strong>Research</strong> in Unani Medicine 52<br />

Five Key <strong>Clinical</strong> Profiles 53<br />

View Full <strong>Report</strong> with TOC @ http://www.radiantinsights.com/research/joint-pain-global-clinicaltrials-review-h1-<strong>2015</strong><br />

Appendix 75<br />

Abbreviations 75<br />

Definitions 75<br />

<strong>Research</strong> Methodology 76<br />

Secondary <strong>Research</strong> 76<br />

About <strong>Global</strong>Data 77<br />

Contact Us 77<br />

Disclaimer 77<br />

Source 78<br />

List of Tables<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Region, <strong>2015</strong>* 7<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> and Average Enrollment by Top Countries, <strong>2015</strong>* 8<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> In Progress by Top Countries, <strong>2015</strong>* 9<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, Asia-Pacific, Top Five Countries, <strong>2015</strong>* 10<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, Europe, Top Five Countries, <strong>2015</strong>* 11


<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, North America, Top Countries, <strong>2015</strong>* 12<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, Middle East and Africa, Top Countries, <strong>2015</strong>* 13<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, Central and South America, Top Countries, <strong>2015</strong>* 14<br />

Proportion of <strong>Joint</strong> <strong>Pain</strong> to Central Nervous System <strong>Clinical</strong> <strong>Trials</strong>, G7 Countries (%), <strong>2015</strong>* 15<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics, G7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Phase, <strong>2015</strong>* 16<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics, G7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 17<br />

Proportion of <strong>Joint</strong> <strong>Pain</strong> to Central Nervous System <strong>Clinical</strong> <strong>Trials</strong>, E7 Countries (%), <strong>2015</strong>* 18<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics, E7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Phase, <strong>2015</strong>* 19<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics, E7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 20<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Phase, <strong>2015</strong>* 21<br />

View Full <strong>Report</strong> with TOC @ http://www.radiantinsights.com/research/joint-pain-global-clinicaltrials-review-h1-<strong>2015</strong><br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> In Progress by Phase <strong>2015</strong>* 22<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 23<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, by End Point Status, <strong>2015</strong>* 24<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics, <strong>Global</strong>, Suspended <strong>Clinical</strong> <strong>Trials</strong>, <strong>2015</strong>* 25<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics, <strong>Global</strong>, Withdrawn <strong>Clinical</strong> <strong>Trials</strong>, <strong>2015</strong>* 26<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics, <strong>Global</strong>, Terminated <strong>Clinical</strong> <strong>Trials</strong>, <strong>2015</strong>* 27<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Average Enrollment Target <strong>Trend</strong>s, 2010-2014 28<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Sponsor Type, <strong>2015</strong>* 29<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Key Sponsors, <strong>2015</strong>* 30<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Top Companies by Phase, <strong>2015</strong>* 31<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Ongoing <strong>Clinical</strong> <strong>Trials</strong> by Prominent Drugs, <strong>2015</strong>* 32<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Novartis AG, <strong>2015</strong>* 33<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Johnson & Johnson, <strong>2015</strong>* 34<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Endo International Plc, <strong>2015</strong>*<br />

35


<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Arthritis <strong>Research</strong> UK, <strong>2015</strong>*<br />

36<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by APIGENEX s.r.o., <strong>2015</strong>* 37<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Amgen <strong>Inc</strong>., <strong>2015</strong>* 38<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by AlgoRx Pharmaceuticals, <strong>Inc</strong>.<br />

(Inactive), <strong>2015</strong>* 39<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Actavis Plc, <strong>2015</strong>* 40<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Accutest <strong>Research</strong> Laboratories<br />

(I) Pvt. Ltd., <strong>2015</strong>* 41<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by ABsize <strong>Inc</strong>., <strong>2015</strong>* 42<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Baylor Breast Care Center,<br />

<strong>2015</strong>* 43<br />

View Full <strong>Report</strong> with TOC @ http://www.radiantinsights.com/research/joint-pain-global-clinicaltrials-review-h1-<strong>2015</strong><br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Creighton University, <strong>2015</strong>* 44<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Iran University of Medical<br />

Sciences, <strong>2015</strong>* 45<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by National Center for<br />

Complementary and Integrative Health, <strong>2015</strong>* 46<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by National Institute of Siddha,<br />

<strong>2015</strong>* 47<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Shiraz University of Medical<br />

Sciences, <strong>2015</strong>* 48<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by The Johns Hopkins University,<br />

<strong>2015</strong>* 49<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Appalachian State University,<br />

<strong>2015</strong>* 50<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Bharati Vidyapeeth Deemed<br />

University, <strong>2015</strong>* 51<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Central Council for <strong>Research</strong> in<br />

Unani Medicine, <strong>2015</strong>* 52


List of Figures<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Region (%), <strong>2015</strong>* 7<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> and Average Enrollment by Top Countries, <strong>2015</strong>* 8<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> In Progress by Top Countries, <strong>2015</strong>* 9<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, Asia-Pacific, Top Five Countries (%), <strong>2015</strong>* 10<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, Europe, Top Five Countries (%), <strong>2015</strong>* 11<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, North America, Top Countries (%), <strong>2015</strong>* 12<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, Middle East and Africa, Top Countries (%), <strong>2015</strong>* 13<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, Central and South America, Top Countries (%), <strong>2015</strong>* 14<br />

Proportion of <strong>Joint</strong> <strong>Pain</strong> to Central Nervous System <strong>Clinical</strong> <strong>Trials</strong>, G7 Countries (%), <strong>2015</strong>* 15<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics, G7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Phase, <strong>2015</strong>* 16<br />

View Full <strong>Report</strong> with TOC @ http://www.radiantinsights.com/research/joint-pain-global-clinicaltrials-review-h1-<strong>2015</strong><br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics, G7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 17<br />

Proportion of <strong>Joint</strong> <strong>Pain</strong> to Central Nervous System <strong>Clinical</strong> <strong>Trials</strong>, E7 Countries (%), <strong>2015</strong>* 18<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics, E7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Phase, <strong>2015</strong>* 19<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics, E7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 20<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Phase (%), <strong>2015</strong>* 21<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> In Progress by Phase, <strong>2015</strong>* 22<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 23<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, by End Point Status, <strong>2015</strong>* 24<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Average Enrollment Target <strong>Trend</strong>s, 2010-2014 28<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Sponsor Type (%), <strong>2015</strong>* 29<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Key Sponsors, <strong>2015</strong>* 30<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Top Companies by Phase, <strong>2015</strong>* 31<br />

<strong>Joint</strong> <strong>Pain</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Ongoing <strong>Clinical</strong> <strong>Trials</strong> by Prominent Drugs, <strong>2015</strong>* 32


<strong>Global</strong>Data Methodology 76<br />

View Full <strong>Report</strong> with TOC @ http://www.radiantinsights.com/research/joint-pain-global-clinicaltrials-review-h1-<strong>2015</strong><br />

About <strong>Radiant</strong> <strong>Insights</strong><br />

<strong>Radiant</strong> <strong>Insights</strong> is a platform for companies looking to meet their market research and business<br />

intelligence requirements. We assist and facilitate organizations and individuals procure market research<br />

reports, helping them in the decision making process. We have a comprehensive collection of reports,<br />

covering over 40 key industries and a host of micro markets. In addition to over extensive database of<br />

reports, our experienced research coordinators also offer a host of ancillary services such as, research<br />

partnerships/ tie-ups and customized research solutions.<br />

For More Information, Visit <strong>Radiant</strong> <strong>Insights</strong><br />

Contact:<br />

Michelle Thoras<br />

Corporate Sales Specialist, USA<br />

<strong>Radiant</strong> <strong>Insights</strong>, <strong>Inc</strong><br />

Phone: 1-415-349-0054<br />

Toll Free: 1-888-202-9519<br />

Email: sales@radiantinsights.com<br />

Blog URL: http://www.radiantinsightsinc.blogspot.com

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!